Kiniksa Pharmaceuticals International, plc
KNSA
$31.98
$1.725.68%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 307.78M | 268.34M | 243.63M | 223.78M | 218.76M |
| Total Receivables | 31.91M | 40.07M | 41.72M | 24.89M | 20.45M |
| Inventory | 48.18M | 22.07M | 26.36M | 28.68M | 34.86M |
| Prepaid Expenses | 32.44M | 25.43M | 20.08M | 33.95M | 26.95M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 420.31M | 355.91M | 331.80M | 311.30M | 301.02M |
|
|
|||||
| Total Current Assets | 420.31M | 355.91M | 331.80M | 311.30M | 301.02M |
| Net Property, Plant & Equipment | 11.38M | 11.06M | 11.04M | 11.66M | 12.40M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 15.75M | 16.00M | 16.25M | 16.50M | 16.75M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 213.71M | 216.36M | 221.47M | 215.84M | 212.25M |
| Total Assets | 661.15M | 599.33M | 580.55M | 555.30M | 542.43M |
|
|
|||||
| Total Accounts Payable | 8.96M | 1.98M | 2.04M | 8.33M | 7.39M |
| Total Accrued Expenses | 88.35M | 75.90M | 80.51M | 69.53M | 63.32M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 2.52M | 2.29M | 1.99M | 2.03M | 2.09M |
| Total Finance Division Other Current Liabilities | 18.00M | 17.09M | 16.08M | 16.07M | 11.50M |
| Total Other Current Liabilities | 18.00M | 17.09M | 16.08M | 16.07M | 11.50M |
| Total Current Liabilities | 117.83M | 97.27M | 100.62M | 95.96M | 84.29M |
|
|
|||||
| Total Current Liabilities | 117.83M | 97.27M | 100.62M | 95.96M | 84.29M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 7.24M | 7.62M | 7.86M | 8.56M | 9.32M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 41.07M | 36.95M | 33.63M | 13.77M | 13.73M |
| Total Liabilities | 166.14M | 141.84M | 142.12M | 118.29M | 107.33M |
|
|
|||||
| Common Stock & APIC | 989.83M | 970.26M | 959.74M | 949.30M | 934.79M |
| Retained Earnings | -494.77M | -512.60M | -521.14M | -512.26M | -499.56M |
| Treasury Stock & Other | -53.00K | -165.00K | -163.00K | -41.00K | -130.00K |
| Total Common Equity | 495.01M | 457.49M | 438.44M | 437.01M | 435.10M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 495.01M | 457.49M | 438.44M | 437.01M | 435.10M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 495.01M | 457.49M | 438.44M | 437.01M | 435.10M |
|
|
|||||